University of North Carolina, Chapel Hill

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of North Carolina, Chapel Hill sits in the top decile of US sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count).

1,109 total trials 108 currently recruiting 881 completed early-phase tilt top decile by trial count

University of North Carolina, Chapel Hill: 1,109 sponsored US clinical trials, 108 recruiting.

University of North Carolina, Chapel Hill sponsors 1,109 registered US clinical trials on ClinicalTrials.gov, 108 of them currently recruiting, and 881 completed. 69 of these trials are in Phase 3-4 (later-stage) and 203 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.

Top-decile sponsor footprint

University of North Carolina, Chapel Hill ranks in the top decile of sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 69/100

881 of 962 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,109 total, page 4 of 23

COMPLETED NA

Testing Ultraprocessed Food Labels in Chile

NCT06842680

COMPLETED NA

High Intensity Resistance Training + Creatine in Perimenopause

NCT07027800

COMPLETED NA

Public Support for Prison Nutrition Standards

NCT06840600

COMPLETED NA

Feasibility and Acceptability of PREVAIL (PREserving Valued Activities In Life)

NCT06706999

COMPLETED NA

Psychotherapy Feasibility Pilot of the Carolina Recovery From Depression Protocol

NCT06590038

COMPLETED NA

Patient Understanding of Handouts at Different Reading Levels

NCT06736808

TERMINATED NA

Expediting Access to Services for Equity

NCT06291246

COMPLETED NA

PeLear CCC: Proyecto Latino Contra Cancer Colorrectal

NCT06426927

COMPLETED NA

Impacts of Alcohol Warning Labels: An Online Experiment

NCT06442800

COMPLETED NA

Written Exposure Therapy to Improve Recovery Among Sexual Assault Survivors

NCT06571513

COMPLETED NA

Altitudes: A Digital Intervention to Support Caregivers

NCT06509100

COMPLETED NA

Satiety and Alcohol Challenge

NCT06576674

COMPLETED NA

Food and Friends: Healthy Meals Delivered to You

NCT06415370

COMPLETED NA

Message Framing and Policy Support for Front-of-package Labeling

NCT06296342

COMPLETED NA

Front-of-package Label Effects in Latine and Limited English Proficiency Populations

NCT06293963

COMPLETED NA

Impacts of Warning Labels on Ultra-Processed Foods

NCT06296355

COMPLETED NA

Impact of Front-of-package Labels on Weight Bias Among Latines

NCT06293937

COMPLETED NA

COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial

NCT06547814

COMPLETED

Ultrasound Estimation of Gastric Volumes in Patients With Previous Gastric Sleeve

NCT06533046

COMPLETED NA

Pilot of Pragmatic Delivery of Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes

NCT06405386

COMPLETED NA

Efficacy of Recombinant Bovine Lactoferrin (rbLf) in Iron Regulation

NCT06428357

TERMINATED NA

Building Equitable Linkages With Interprofessional Education Valuing Everyone

NCT06483022

COMPLETED NA

Early Patient Removal of Urinary Catheters After Urogynecologic Surgery

NCT06344884

COMPLETED NA

Safety, Tolerability, and Biosignature of Humanized Prebiotics in Healthy Adults

NCT06068894

TERMINATED NA

SMILE: Clinical Trial to Evaluate Mindfulness as Intervention for Racial and Ethnic Populations During COVID-19

NCT06242080

COMPLETED NA

Med-South Lifestyle Program for Pregnancy

NCT06374199

TERMINATED NA

Effects of SinuSonic on Psychological and Physical Well-Being

NCT06268730

COMPLETED NA

Metabolic Effects of Perimenopause

NCT06098183

COMPLETED NA

Self-Compassion to Enhance the Well-Being of Caregivers of Children With Physical Disabilities

NCT06271824

COMPLETED

Comparing Train-of-Four Recovery in the Adductor Pollicis Versus the Adductor Digiti Minimi in Elective Surgery Patients

NCT06467448

COMPLETED NA

Feasibility and Acceptability of a Stigma Text Message Intervention for People Who Use Drugs

NCT06281548

COMPLETED NA

Food as Medicine for Families

NCT06160973

COMPLETED NA

Online Family Dyadic Skills Training for Black Adults in Behavioral Weight Loss Program

NCT05981508

COMPLETED NA

Mitigating Mental Health Issues Among Women's Sport Student-Athletes Through a Moderate-Intensity Exercise Intervention

NCT06182150

COMPLETED NA

Impact of Front-of-package Warning Labels on Perceived Weight Stigmatization

NCT06179043

COMPLETED NA

Altitudes for Caregivers

NCT06094647

TERMINATED NA

Horyzons: Implementation and Integration in Clinical Practice

NCT06002958

COMPLETED NA

Impact of Environmental Nudges on Dietary Quality

NCT06119165

TERMINATED Phase 4

Antiseizure Medication in Seizure Networks at Early Acute Brain Injury

NCT06081283

COMPLETED

Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.

NCT06038734

TERMINATED NA

COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists

NCT05926544

COMPLETED NA

PATH to Health: An Exploration of Digital Behavioral Weight Loss Approaches

NCT05929469

COMPLETED NA

The Pain Intervention Via Video Optimization Trial

NCT06035575

COMPLETED NA

Self-monitoring and Reflection's Impact on Psychotherapy Outcomes: A Trial Protocol.

NCT06038747

COMPLETED NA

PROmoting Diabetes Education and Management Through Peer Support and Team Referral

NCT05587348

COMPLETED NA

Pilot Study on Training Emerging Adults Skills in Navigating College

NCT05560425

COMPLETED

Evaluation of MABOS for Improved Pulse Oximeter Accuracy in Patients of Color

NCT05995613

COMPLETED NA

Supporting Tailored And Responsive PrEP in Rural North Carolina

NCT05984030

COMPLETED NA

Just-in-time Adaptive Intervention Messaging in a Digital Weight Loss Intervention for Young Adults

NCT05625061

COMPLETED NA

Time Restricted Eating for Metabolic and Psychological Optimization

NCT05997316

← Previous Page 4 of 23 Next →

Phase Distribution

PhaseTrial count
Phase 1 111
Phase 2 92
Phase 3 13
Phase 4 56

What is open in the University of North Carolina, Chapel Hill pipeline

108 recruiting of 1,109 indexed (10% open); 881 completed (79%).

Phase mix: 69 late (III/IV) vs 203 early (I/II) (early-phase heavy).

Top condition: Obesity (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of North Carolina, Chapel Hill: open-pipeline peers nationwide

Peers matched on 1,109 registered trials and 10% open enrollment, not the therapeutic-area sidebar.

University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 8%10%12%14%16%18%20% Total trials Recruiting share University of North Carolina, Chapel HillUniversity of FloridaWake Forest University Health SciencesUniversity of Alabama at BirminghamNYU Langone HealthChildren's Hospitals and Clinics of MinnesotaCytokineticsSanofiOhio University
University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,109 trials (± recruiting share)

Sponsors near 10% open enrollment (± trial volume)

What to do with this University of North Carolina, Chapel Hill page

1,109 registered trials is a research-attention snapshot, not an endorsement of University of North Carolina, Chapel Hill or any single study.

  • 108 of University of North Carolina, Chapel Hill's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition University of North Carolina, Chapel Hill studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of North Carolina, Chapel Hill pipeline card: 1,109 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.